Ricerche di mercato sul turismo medico

Il turismo medico è un settore in crescita in tutto il mondo a causa dell’aumento dei costi delle cure sanitarie nei paesi d’origine, della globalizzazione del settore sanitario e del crescente accesso a operatori sanitari qualificati in tutto il mondo. I paesi dei mercati emergenti stanno dando priorità a questo settore per attrarre turisti medici e incrementare le esportazioni di settori di servizi avanzati come la sanità, la biotecnologia e il settore farmaceutico.
Il turismo medico è definito come il processo di viaggio fuori dal paese di residenza per ricevere cure mediche. Sebbene molti identifichino il turismo medico come persone che viaggiano da paesi ricchi a paesi in via di sviluppo per ricevere cure mediche più economiche, il processo si applica anche alla situazione opposta in cui persone provenienti da paesi meno sviluppati viaggiano verso economie ricche per eseguire operazioni non facilmente eseguibili nei loro paesi d’origine. .
SIS analizza tutte le potenziali opportunità offerte da questo modo di lavorare e il modo in cui i potenziali clienti e fornitori possono prosperare e migliorare i trattamenti.
About the Medical Tourism Market
Il turismo medico è presente in quasi tutti i paesi del mondo. Ad esempio, i residenti negli Stati Uniti si recano in Messico, Canada o nei paesi dell’America centrale e meridionale per usufruire di un’assistenza sanitaria più economica, mentre gli europei viaggiano al di fuori dell’UE o tra paesi in cui i prezzi sono più bassi.
Alcune delle destinazioni più popolari sono Cuba, Grecia, Tailandia, Corea e Serbia perché i loro medici e specialisti sono tra i migliori al mondo.
I motivi più comuni per cui le persone si recano in un altro Paese per cure mediche sono:
- Prezzo (molte persone viaggiano in altri paesi perché non possono permettersi un’assicurazione medica da sole o perché i costi della procedura sono molto al di sopra del loro budget, quindi possiamo concludere che questo è il motivo principale del turismo medico)
- La legalità del servizio (alcuni servizi sanitari come l'aborto o l'eutanasia sono vietati dalla legge in alcuni paesi, ma non in tutti)
Differenze culturali (molti immigrati vogliono essere curati nel loro paese di origine, a causa delle loro convinzioni religiose) - Accesso alle procedure sperimentali
- Accesso a una migliore qualità delle cure
Tra le procedure che le persone decidono di recarsi in un altro Paese ci sono (ma non sono limitate a): trattamenti per la fertilità (ad esempio maternità surrogata, fecondazione in vitro e tecnologie di riproduzione assistita), trapianti di organi, chirurgia plastica, cure dentistiche e trattamenti sperimentali contro il cancro.
Ricerche di mercato sul percorso del cliente can uncover numerous sources of competitive advantage in the Medical Tourism sector. Customers face numerous benefits and risks in medical tourism and the stakes can be high. Before patients decide to have their procedure done in a foreign country, they often conduct comprehensive in-person and online research to pick the right facility, treatment and medical provider for his or her needs. As these decisions can be outside their domestic medical establishments, the online research that patients conduct is important in their decision making. Furthermore, people who opt for medical tourism often exhaust all available medical treatment options in their home country so they can be a vulnerable group requiring information about benefits and risks. Market Research provides the insight for Medical Tourism providers to better serve potential patients.
Le complicazioni più comuni del turismo medico includono:
- Malattie e rischio di infezioni – dalle complicazioni procedurali (ferite o infezioni derivate dal donatore) alle malattie infettive se una persona viaggia in paesi lontani
- Resistenza agli antibiotici – questo è un rischio relativamente raro, ma ogni turista medico deve esserne consapevole
- Problemi di comunicazione – solo le strutture registrate possono fornire al personale una conoscenza avanzata della lingua inglese o della lingua madre del paziente, essenziale per una corretta cura
- Viaggio aereo: se i pazienti volano subito dopo l'intervento, sono ad alto rischio di coaguli di sangue o altri rischi di viaggio, quindi è consigliabile attendere almeno 10-14 giorni prima di tornare a casa
Medical Ricerche di mercato nel turismo: How Leading Operators Build Cross-Border Patient Pipelines
Medical tourism market research has shifted from descriptive country profiling to operational intelligence that informs corridor selection, payer partnerships, and clinical specialty positioning. The sophisticated buyers in this category, hospital networks, sovereign health funds, insurer-employer coalitions, and private equity-backed specialty groups, treat patient flow modeling the way airlines treat route economics.
The global cross-border patient market spans elective orthopedics, oncology second opinions, fertility, dental, cardiac, and bariatric procedures. Each travels along distinct corridors with distinct economics. Mexico-US dental and bariatric flows behave nothing like Gulf-to-Germany oncology referrals or China-to-Japan precision medicine cases. Treating them as a single market produces unusable forecasts.
Why Corridor-Level Medical Tourism Market Research Outperforms Country Reports
Country-level sizing obscures the unit of competition. Patients do not choose Thailand. They choose a specific Bangkok hospital with JCI accreditation, a named surgeon, an English-speaking concierge, and a payer arrangement that covers travel. Corridor analysis isolates origin-destination pairs and decomposes them into procedure mix, payer source, facilitator margin, and length-of-stay economics.
The leading operators model corridors the way logistics firms model lanes. Singapore-Indonesia cardiac. Turkey-UK hair restoration and dental. Costa Rica-US dental and orthopedics. Korea-China aesthetic surgery. India-East Africa oncology. Each corridor has a distinct conversion funnel from inquiry to deposit to arrival to follow-up, and the leakage points differ.
According to SIS International Research, the operators winning share in mature corridors invest heavily in pre-arrival clinical triage, often a structured remote consultation that qualifies the patient and pre-builds the care plan. This single step compresses on-site length of stay, reduces clinical surprises, and lifts deposit-to-arrival conversion materially above facilitator-led alternatives.
The Five Forces Reshaping Cross-Border Patient Flows
Five structural forces govern where the next decade of growth concentrates. Each is measurable and each rewards firms that build proprietary intelligence rather than rely on syndicated reports.
Payer integration. Self-funded US employers, UK NHS overflow contracting, and Gulf state-sponsored programs have moved from pilot to procurement. The buyer is no longer the patient. It is a benefits committee or a sovereign health authority running an RFP with bundled-price expectations and outcomes reporting requirements.
Accreditation as table stakes. JCI, Temos, and ISO 9001 certifications no longer differentiate. The differentiator is publishing risk-adjusted outcomes by surgeon and procedure, the standard set by Bumrungrad, Anadolu Medical Center, and Apollo Hospitals.
Facilitator disintermediation. Hospitals with mature international patient departments, Gleneagles, Asan Medical Center, Hospital Israelita Albert Einstein, are building direct payer relationships and bypassing traditional facilitators on high-margin cases.
Telemedicine pre-screening. Remote second opinions have become the top of the funnel. The hospital that captures the second opinion captures a disproportionate share of conversions.
Visa, currency, and geopolitical friction. Corridor economics shift quickly with visa policy and exchange rates. Turkey’s lira depreciation rebuilt its dental and aesthetic corridors within two years. Sanctions and travel restrictions can collapse a corridor in a quarter.
What Sophisticated Medical Tourism Market Research Actually Measures
Descriptive market sizing is the entry-level deliverable. The intelligence that informs capital allocation goes deeper.
| Research Layer | What It Measures | Decision It Informs |
|---|---|---|
| Corridor sizing | Procedure-level patient volumes by origin-destination pair | Market entry, capacity planning |
| Payer mapping | Self-pay vs employer-funded vs sovereign-sponsored mix | Channel investment, pricing |
| Facilitator economics | Commission structures, lead quality, conversion rates | Direct vs intermediated channel mix |
| Clinical outcomes benchmarking | Risk-adjusted complication and revision rates | Specialty positioning, payer contracting |
| Patient journey ethnography | Decision triggers, anxiety points, post-op follow-up gaps | Service design, retention |
Source: SIS International Research
The patient journey layer is where most market entry decks are weakest. Cross-border patients make decisions across an eight-to-fourteen-week window with multiple household stakeholders, and the conversion-killing moments are rarely clinical. They are visa anxiety, deposit refund policy ambiguity, and post-arrival communication gaps.
The SIS Approach to Medical Tourism Market Research
SIS International’s healthcare practice combines structured B2B expert interviews with international patient department directors, ethnographic research with returning patients, and competitive intelligence on hospital pricing, accreditation, and outcomes disclosure. A recent mixed-methodology engagement targeted 200 respondents across Brazil to map inbound and outbound patient flows for a Fortune 500 healthcare client evaluating Latin American corridor expansion.
The healthcare practice has fielded patient-side and provider-side studies across China, Mexico, the United States, Germany, Korea, Singapore, and Israel, including direct CEO-level interviews with overseas medical services agencies serving outbound Chinese patients. This dual-perspective design, capturing both the originating facilitator and the receiving hospital, surfaces the pricing and commission realities that single-sided studies miss.
SIS Corridor Viability Framework
Four dimensions determine whether a corridor merits investment.
- Volume durability. Is the patient flow tied to a structural cost or capacity gap, or to a temporary currency arbitrage?
- Payer concentration. Are the buyers individuals or institutional payers with renewable contracts?
- Clinical defensibility. Does the destination have outcomes data and surgeon depth that withstand a malpractice-conscious payer audit?
- Operational maturity. Are the international patient department, concierge, billing, and follow-up workflows institutionalized or improvised?
Corridors strong on all four, Singapore cardiac, Korea oncology, Turkey dental and orthopedics, sustain investment through currency cycles. Corridors weak on payer concentration or clinical defensibility tend to be margin-thin and reputation-fragile.
Where the Market Goes Next
Three shifts will define the next phase of corridor competition. First, employer-direct contracting will move from pilot programs at large self-funded US employers into mid-market benefits design, expanding addressable demand for centers of excellence in Mexico, Costa Rica, and Colombia. Second, fertility tourism will continue to outgrow other categories as regulatory arbitrage and donor availability concentrate volume in Spain, Greece, the Czech Republic, and parts of Latin America. Third, oncology second opinions delivered remotely will become the primary acquisition channel for high-acuity cross-border cases.
SIS International’s structured expert interviews with overseas medical services agencies indicate that destination preference among high-net-worth outbound patients is driven less by price and more by perceived clinical reputation, language infrastructure, and the agency’s own relationships with named physicians at receiving hospitals. The implication for hospitals is that physician-level brand investment outperforms institutional marketing in this segment.
Medical tourism market research that informs board-level decisions does not stop at market size. It quantifies corridor durability, payer concentration, clinical defensibility, and operational readiness, and it does so with primary evidence from both ends of the patient journey.
A proposito di SIS Internazionale
SIS Internazionale offre ricerca quantitativa, qualitativa e strategica. Forniamo dati, strumenti, strategie, report e approfondimenti per il processo decisionale. Conduciamo anche interviste, sondaggi, focus group e altri metodi e approcci di ricerca di mercato. Contattaci per il tuo prossimo progetto di ricerca di mercato.

